Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE 2024-07-12 04:00
Medit Appoints Han Ryu as CEO, Focusing on Customer-Centric Innovation 2024-07-11 21:00
First Patient Dosed in Phase I Clinical Trial of YOLT-201 2024-07-11 20:11
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC 2024-07-11 20:00
Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL) 2024-07-11 14:21
ADM Korea Announces Niclosamide-based Metabolic Anticancer Drug's First Clinical Trial Target as 'Prostate Cancer Patients Resistant to Hormone Therapy' 2024-07-11 14:07
Official Swiss delegation experiences new frontiers in art tech at HKBU 2024-07-11 13:34
Kangsters Unveils Revolutionary Treadmills at Rollettes Experience 2024: Celebrating Innovation and Empowerment 2024-07-11 00:00
Snorles GenioFlex: The Innovative Daytime Solution for Snoring Management Now Launched on Indiegogo 2024-07-10 20:02
WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year 2024-07-10 13:30
KOSÉ, I Peace, and Reju Enter Strategic Partnership to Develop Personalized Beauty Products Based on iPS Cells 2024-07-09 23:00
Bestqool Pro Series Redefines the Standard of Red Light Therapy Devices: Cutting-Edge Technology Undergone the Third-party Laboratory Diagnostic Testing 2024-07-09 21:00
Goodix Launches Its Latest Automotive-Grade Bluetooth LE SoC and CGM Solutions at electronica China 2024 2024-07-08 22:00
Porton J-STAR and Enabling Technologies Consortium Collaboration on Co-processing Platform Technology Development 2024-07-08 22:00
Alteogen Receives Ministry of Food and Drug Safety (MFDS) Approval for Tergase® 2024-07-08 21:00
DP Technology Announces Nomination of Development Candidate, a CNS Penetrable Lp-PLA2 Inhibitor for Alzheimer's Disease 2024-07-08 17:23
DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Lp-PLA2 Inhibitor for DR and DME 2024-07-08 17:00
Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors 2024-07-08 16:28
BioCity announces its endothelin receptor A selective antagonist SC0062 met the primary endpoint in IgA nephropathy in 2-SUCCEED trial: a randomized, double-blind, placebo-controlled Phase 2 trial 2024-07-08 13:41
Hainan Free Trade Port deepens cooperation with Switzerland 2024-07-07 22:36
1 33 34 35 36 37 809